Indonesia’s Commission IX has urged for a cautious approach towards the legalization of kratom, emphasizing the need for scientific validation of its benefits. Edy Wuryanto, a member of the commission, stressed the importance of rigorous clinical trials and strict supervision by the Food and Drug Monitoring Agency (BPOM). The call for caution comes amid rising popularity of kratom, which is often used for its purported benefits in pain relief and mood enhancement. However, concerns over its safety and potential for abuse remain significant. The commission’s stance highlights the ongoing debate over balancing the potential health benefits of kratom with the imperative to ensure public safety. For further details, visit the Jakarta Globe.
Commission IX Calls for Caution in Kratom Legalization Amid Safety Concerns
